Evidence map›Paper›PMID 39173827›Full record

Trial reportChest2025

The Responsiveness of Exercise Tests in COPD: A Randomized Controlled Trial.

Theresa C Harvey-Dunstan, Molly M Baldwin, Ruth Tal-Singer, Matthew Allinder, Michael I Polkey, Alan Hamilton, Matthew Richardson, Sarah A Edwards, Michael C Steiner, Mike D Morgan and 2 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Chest, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07792642 (FITME Study), which is not on this map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07792642 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

FITME Study: Formulating Individualised Exercise Prescription in Chronic Obstructive Pulmonary Disease

TypeinterventionalSponsorAveiro UniversityRan2026 to 2029Enrolled46ConditionsChronic Obstructive Pulmonary Disease (COPD)ArmsNon-pharmacological intervention: Pulmonary rehabilitation programme
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Theresa C Harvey-DunstanInstitute for Lung Health, Leicester NIHR Biomedical Research Centre - Respiratory, Leicester, England.
Molly M BaldwinInstitute for Lung Health, Leicester NIHR Biomedical Research Centre - Respiratory, Leicester, England; Department of Respiratory Sciences, College of Life Sciences, University of Leicester, Leicester, England.
Ruth Tal-SingerGlaxoSmithKline, Philadelphia, PA.
Matthew AllinderGlaxoSmithKline, Philadelphia, PA.
Michael I PolkeyRespiratory Medicine, Royal Brompton & Harefield NHS Foundation Trust, London, England; National Heart and Lung Institute, Imperial College London, London, England.
Alan HamiltonBoehringer Ingelheim (Canada) Ltd., Burlington, ON, Canada.
Matthew RichardsonInstitute for Lung Health, Leicester NIHR Biomedical Research Centre - Respiratory, Leicester, England.
Sarah A EdwardsInstitute for Lung Health, Leicester NIHR Biomedical Research Centre - Respiratory, Leicester, England.
Michael C SteinerInstitute for Lung Health, Leicester NIHR Biomedical Research Centre - Respiratory, Leicester, England; Department of Respiratory Sciences, College of Life Sciences, University of Leicester, Leicester, England.
Mike D MorganInstitute for Lung Health, Leicester NIHR Biomedical Research Centre - Respiratory, Leicester, England; Department of Respiratory Sciences, College of Life Sciences, University of Leicester, Leicester, England.
Sally J SinghInstitute for Lung Health, Leicester NIHR Biomedical Research Centre - Respiratory, Leicester, England; Department of Respiratory Sciences, College of Life Sciences, University of Leicester, Leicester, England. Electronic address: ss1119@le.ac.uk.
COPD/MAP Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOPD is characterized by reduced exercise tolerance, and improving physical performance is an important therapeutic goal. A variety of exercise tests are commonly used to assess exercise tolerance, including laboratory and field-based tests. The responsiveness of these various tests to common COPD interventions is yet to be compared, but the results may inform test selection in clinical and research settings. RESEARCH QUESTION: What exercise test possesses the greatest sensitivity to change from before to after intervention in patients with COPD? STUDY DESIGN AND

methodsOne hundred fifty-four patients with symptomatic COPD were recruited and randomized (2:1:1) to 6 weeks of long-acting muscarinic antagonist, pulmonary rehabilitation (PR), or usual care. Before and after intervention, participants performed an incremental cycle exercise test and constant work rate cycle test (CWRCT), incremental shuttle walk test and endurance shuttle walk test (ESWT), 6-min walk test, and 4-m gait speed test.

resultsOne hundred three participants (mean ± SD age, 67 ± 8 years; 75 male participants [73%]; FEV

interpretationThe ESWT and CWRCT seemed to be the most responsive exercise test protocols to long-acting muscarinic antagonist and PR therapy. The magnitude of change was much greater after a program of rehabilitation compared with bronchodilator therapy. CLINICAL TRIAL REGISTRY: International Standard Randomised Controlled Trial Number (ISRCTN): No. 64759523; URL: https://www.isrctn.com/ISRCTN64759523.

Indexed as

Exercise TestExercise ToleranceMuscarinic AntagonistsPulmonary Disease, Chronic ObstructiveAgedFemaleForced Expiratory VolumeHumansMaleMiddle AgedWalk TestMuscarinic AntagonistsCOPDexercise testingoutcome measurepulmonary rehabilitationresponsiveness

Identifiers

PMID39173827
PMCPMC11752132

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.